Loss of p53 and overexpression of EphA2 predict poor prognosis for ovarian cancer patients

Loss of p53 and overexpression of EphA2 predict poor prognosis for ovarian cancer patients

Analysis of EphA2 Expression and Mutant p53 in Ovarian Carcinoma William M. Merritt, Premal H. Thaker, Charles N. Landen Jr., Michael T. Deavers, Mavis S. Fletcher, Yvonne G. Lin, Liz Y. Han, Aparna A. Kamat, Rosemarie Schmandt, David M. Gershenson, Michael S. Kinch and Anil K. Sood Volume: 5 | Issu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer biology & therapy 2007-02, Vol.6 (2), p.288-289
Hauptverfasser: Meade-Tollin, Linda, Martinez, Jesse D.
Format: Artikel
Sprache:eng
Schlagworte:
Binding
Biology
Biomarkers, Tumor
Bioscience
Calcium
Cancer
Cell
Cycle
Female
Gene Expression Regulation, Neoplastic
Genes, p53 - genetics
Humans
Landes
Organogenesis
Ovarian Neoplasms - genetics
Prognosis
Proteins
Receptor, EphA2 - biosynthesis
Up-Regulation
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Analysis of EphA2 Expression and Mutant p53 in Ovarian Carcinoma William M. Merritt, Premal H. Thaker, Charles N. Landen Jr., Michael T. Deavers, Mavis S. Fletcher, Yvonne G. Lin, Liz Y. Han, Aparna A. Kamat, Rosemarie Schmandt, David M. Gershenson, Michael S. Kinch and Anil K. Sood Volume: 5 | Issue: 10 | Pages: 1357 - 1360
ISSN:1538-4047
1555-8576
DOI:10.4161/cbt.6.2.4024